Skip to main content
Contact Us
Subscribe
E-Edition
67°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Selecta Biosciences
(NQ:
SELB
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EST, Nov 13, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Selecta Biosciences
< Previous
1
2
3
4
Next >
Selecta Biosciences Merges Cartesian To Focus On Autoimmune Cell Therapy
November 13, 2023
Selecta Biosciences Inc (NASDAQ: SELB) and Cartesian Therapeutics Inc announced a reverse merger in an all-stock deal, with Selecta shareholders owning
Via
Benzinga
Analyst Ratings for Selecta Biosciences
August 18, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 18, 2023
August 18, 2023
Via
Benzinga
Recap: Selecta Biosciences Q1 Earnings
May 04, 2023
Via
Benzinga
What 6 Analyst Ratings Have To Say About Selecta Biosciences
April 13, 2023
Via
Benzinga
The Latest Analyst Ratings for Selecta Biosciences
March 22, 2023
Via
Benzinga
Selecta Biosciences Earnings Perspective: Return On Capital Employed
March 08, 2023
Via
Benzinga
Earnings Preview For Selecta Biosciences
March 01, 2023
Via
Benzinga
Selecta Biosciences Narrows R&D Focus On Gout Candidate
August 17, 2023
Selecta Biosciences Inc (NASDAQ: SELB) provided an update on its ongoing strategic initiative to maximize stockholder value related to its economic interests in SEL-212, which is being developed for...
Via
Benzinga
Selecta, SOBI's Chronic Refractory Gout Program Meets Primary Goal, US Submission Expected Next Year
March 21, 2023
Via
Benzinga
Why Cerberus Cyber Sentinel Shares Are Trading Higher By 147%; Here Are 20 Stocks Moving Premarket
March 21, 2023
Gainers Cerberus Cyber Sentinel Corporation (NASDAQ: CISO) shares rose 147% to $0.5682 in pre-market trading. Cerberus Cyber Sentinel said it sees Q4 revenue of $14.7 million and sees FY22 revenue of...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
March 21, 2023
We're starting off the day with a look at the biggest pre-market stock movers traders need to know about on Tuesday morning!
Via
InvestorPlace
5 Value Stocks In The Healthcare Sector
February 13, 2023
Via
Benzinga
Selecta Biosciences's Return On Capital Employed Insights
November 23, 2022
Via
Benzinga
A Look Into Healthcare Sector Value Stocks
November 21, 2022
Via
Benzinga
The 7 Best Biotech Stocks to Buy for February 2023
February 07, 2023
Following the wave of red ink last year, astute investors should target the best biotech stocks to buy this month for strong growth potential.
Via
InvestorPlace
Analyst Says Selecta Biosciences' Gout Candidate Can Potentially Raise The Bar On Several Fronts
January 31, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
November 17, 2022
Via
Benzinga
Selecta Biosciences: Q3 Earnings Insights
November 03, 2022
Selecta Biosciences (NASDAQ:SELB) reported its Q3 earnings results on Thursday, November 3, 2022 at 08:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Selecta Biosciences's Earnings Outlook
November 02, 2022
Selecta Biosciences (NASDAQ:SELB) is set to give its latest quarterly earnings report on Thursday, 2022-11-03. Here's what investors need to know before the announcement. Analysts estimate that Selecta...
Via
Benzinga
Earnings Scheduled For November 3, 2022
November 03, 2022
Companies Reporting Before The Bell • Hyatt Hotels (NYSE:H) is estimated to report quarterly earnings at $0.28 per share on revenue of $1.45 billion.
Via
Benzinga
Why Rogers Shares Are Trading Sharply Lower; Here Are 33 Stocks Moving Premarket
November 02, 2022
Gainers Avinger, Inc. (NASDAQ: AVGR) rose 32% to $1.36 in pre-market trading. Avinger is expected to release its financial results for the third quarter on Wednesday, November 9, 2022.
Via
Benzinga
Match Group, Super Micro Computer And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
November 02, 2022
U.S. stock futures traded slightly higher this morning. Here are some big stocks recording gains in today’s pre-market trading session.
Via
Benzinga
Selecta Biosciences's Return On Capital Employed Overview
August 22, 2022
Pulled from Benzinga Pro data, Selecta Biosciences (NASDAQ:SELB) showed a loss in earnings since Q1, totaling $8.60 million. Sales, on the other hand, increased by 15.51% to $39.27 million during Q2.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
August 05, 2022
Via
Benzinga
Why Quoin Pharmaceuticals Plunged Over 62%; Here Are 120 Biggest Movers From Friday
August 08, 2022
Gainers
Via
Benzinga
Why Cooper-Standard Is Trading Higher By 70%, Here Are 81 Stocks Moving In Friday's Mid-Day Session
August 05, 2022
Gainers Assure Holdings Corp. (NASDAQ: IONM) shares jumped 88.8% to $3.9650 after jumping around 104% on Thursday.
Via
Benzinga
Biotech Daily: Amgen, Gilead Go Shopping, Nod For AstraZeneca's Lynparza In Early Stage Breast Cancer, Decision Day For Alzheimer's Associated Hallucinations Candidate
August 04, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
June 22, 2022
Good morning! It's time to start off another busy day of trading with a look at the biggest pre-market stock movers for Wednesday!
Via
InvestorPlace
Expert Ratings for Selecta Biosciences
June 21, 2022
Over the past 3 months, 4 analysts have published their opinion on Selecta Biosciences (NASDAQ:SELB) stock. These analysts are typically employed by large Wall Street banks and tasked with...
Via
Benzinga
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.